Date:11/30/2011

oing may contain certain forward-looking statements that involve risks and uncertainties, including uncertainties associated with the medical device industry. Except for the historical information contained herein, the matters set forth in this press release, including statements relating to patient experience and  employee & employer benefits are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements speak only as of the date the statements are made and are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events. You should not put undue reliance on any forward-looking statements. Important factors that could cause actual performance and results to differ materially from the forward-looking statements we make include: clinical effectiveness, range of treatment options, clinical applications, and market acceptance of products and other risks detailed from time to time under the heading "Risk Factors" in our report on Form 10-K for our 2011 fiscal year, our form 10-Q filed on November 8, 2011 and our other filings with the Securities and Exchange Commission. The Company's actual results of operations may differ significantly from those contemplated by such forward-looking statements as a result of these and other factors. We assume no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws.

'/>"/>

SOURCE Accuray Incorporated Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine technology :

1. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
2. Accuray Receives 510(k) Clearance for a Rotational Dose Control for the TomoTherapy System
3. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2012
4. Accuray Ranked 274th Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
5. Accuray Unveils CyberKnife and TomoTherapy Product Enhancements and Service Offerings at ASTRO 2011
6. Accuray Incorporated to Speak at JMP Securities Healthcare Conference
7. Accuray Hires Chief Commercial Officer
8. Accuray Announces Results for Fourth Quarter and Fiscal Year 2011
9. Accuray Incorporated to Speak at UBS Global Life Sciences Conference
10. Accuray Extends Industry-Leading Customer Service Program to TomoTherapy Systems
11. Accuray Launches New Organization for CyberKnife® and TomoTherapy® System Users